Allergy Unit, Dept. of Dermatology, Unviersity Hosptial of Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Location status: Recruiting
NCT Number: NCT04240522
Atopic dermatitis (AD) is a frequent chronic relapsing inflammatory skin disorder, characterized by intensely itchy eczema. AD usually starts within the first 2 years of life. In 30 - 60% of children, inflammation spreads onto other body surfaces such as the gastrointestinal tract, the respiratory tract, and the conjunctives within a few years. This sequence is called atopic march.
Atopic dermatitis and associated atopic diseases are more frequent in families, suggesting a genetic predisposition. However, the underlying factors such as genetic phenotype, environmental factors, or life style which cause or worsen an existing allergic disease are not understood yet. Affected people suffer from recurrent flares that result in significantly impaired quality.
This study will collect clinical and laboratory data to elucidate immunotolerance and preventiv stategies with the aim to develop new and individual treatment options of atopic diseases.
Interested in participating?
Request Info1 year–85 year
All sexes
Observational
Zurich, Canton of Zurich, 8091, Switzerland
Location status: Recruiting
Primary Objetive:
In the planned project, the main objective is to identify endogenous (e.g. immunological and molecular factors) and exogenous factors (e.g. environmental, socioeconomic and microbial factors) that influence the course and remission of AD. More specifically to identify factors that are significantly different between patients that have or do not have remission from AD.
Secondary Objective:
(i) To identify endogenous and exogenous factors such as immunological, molecular and microbial factors to separate subgroups of patients (endotypes) with distinct local and systemic inflammatory responses.
(ii) To identify potential biomarkers predicting the individual clinical course of AD and other atopic diseases including asthma, food allergy and allergic rhinitis.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The inclusion criteria for healthy controls in this study are as follows:
Written consent will be obtained after detailed information of the study was given to the participant.
Exclusion criteria
Time frame: 5 years
Prospective observational study
Time frame: 5 years
Prospective observational study
Time frame: 5 years
Prospective observational study
University of Zurich
Other
Prospective Longitudinal Observational Research Study to Investigate the Remission of Atopic Dermatitis and Associated Allergic Diseases
Acronym: ProRaD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05689151
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Amiens, Somme, France
View Trial DetailsNCT07527923
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Leuven, Vlaams-Brabant, Belgium
View Trial DetailsNCT07599813
Atopic, Atopic Dermatitis
Birmingham, Alabama, United States
View Trial DetailsNCT07037901
Atopic Dermatitis, Atopic Dermatitis Eczema
Lancaster, California, United States
View Trial Details